Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

ARA-290 Men Over 40: Mechanism Comparison

Understanding where ARA-290 fits relative to other research peptides clarifies its specific role in aging-related research protocols. ARA-290 Innate repair receptor agonist. Reduces apoptosis and inflammatory cytokine release Neurons, cardiomyocytes, pancreati

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Understanding where ARA-290 fits relative to other research peptides clarifies its specific role in aging-related research protocols.
  • ARA-290
  • Innate repair receptor agonist. Reduces apoptosis and inflammatory cytokine release
  • Neurons, cardiomyocytes, pancreatic beta cells, endothelial cells
  • High. Addresses baseline inflammatory drift and oxidative stress without erythropoietic effects
  • Best for tissue-protective research without hematocrit risk
  • BPC-157
  • Promotes angiogenesis, modulates nitric oxide and growth factor pathways
  • Gastrointestinal mucosa, tendons, ligaments, vascular endothelium
  • Moderate. Accelerates tissue repair but less specific to inflammatory modulation
  • Best for acute injury recovery and GI repair
  • Thymosin Alpha-1
  • T-cell maturation and immune modulation. Enhances Th1 response
  • Thymus, peripheral immune cells
  • High. Immune senescence accelerates after 40, TA1 supports adaptive immunity
  • Best for immune system support and infection resistance
  • Epithalon
  • Telomerase activation and circadian rhythm regulation via pineal gland
  • Pineal gland, circadian regulatory centers
  • Moderate. Theoretical longevity effects but limited human trial data
  • Best for circadian and theoretical anti-aging research
  • ARA-290 men over 40 research distinguishes itself by focusing on tissue protection under metabolic and oxidative stress rather than growth promotion or immune activation. It's not a replacement for peptides that enhance angiogenesis like BPC 157 or immune modulators like Thymosin Alpha 1, but it addresses a different layer of the aging phenotype. The chronic low-grade inflammation and impaired stress resistance that accumulate silently over decades.